Yehia Hashad
Chief Tech/Sci/R&D Officer chez BAUSCH + LOMB CORPORATION
Fortune : 2 M $ au 31/03/2024
Profil
Yehia Hashad is currently the Director at the National Alliance for Eye & Vision Research, Director at the Glaucoma Research Foundation, Member-Executive Board at the Reeve-Irvine Research Center, Chief Medical Officer & EVP-Research & Development at Bausch + Lomb Corp., and Senior VP & Global Head-Research & Development at Allergen Aesthetics.
He previously worked as the Director at Beacon Therapeutics (USA), Inc. and as the VP & Global Head-Ophthalmology Therapeutic Areas at Allergan, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/03/2024 | 102 271 ( 0,03% ) | 2 M $ | 31/03/2024 |
Postes actifs de Yehia Hashad
| Sociétés | Poste | Début |
|---|---|---|
| BAUSCH + LOMB CORPORATION | Chief Tech/Sci/R&D Officer | 31/01/2022 |
| Allergen Aesthetics | Chief Tech/Sci/R&D Officer | 01/05/2020 |
Glaucoma Research Foundation
 Glaucoma Research Foundation Miscellaneous Commercial ServicesCommercial Services Glaucoma Research Foundation provides education services. The non-profit company is based in San Francisco, CA. The company was founded by Adrienne L. Graves. The CEO is Thomas M. Brunner. | Director/Board Member | - |
| National Alliance for Eye & Vision Research | Director/Board Member | - |
| Reeve-Irvine Research Center | Corporate Officer/Principal | - |
Anciens postes connus de Yehia Hashad
| Sociétés | Poste | Fin |
|---|---|---|
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Director/Board Member | 01/12/2022 |
| ALLERGAN, INC. | Corporate Officer/Principal | 01/04/2019 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BAUSCH + LOMB CORPORATION | Health Technology |
| Entreprise privées | 6 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Beacon Therapeutics (USA), Inc.
 Beacon Therapeutics (USA), Inc. Pharmaceuticals: GenericHealth Technology Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the usage of a gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. The firm also focuses on conducting clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL. | Health Technology |
| National Alliance for Eye & Vision Research | |
Glaucoma Research Foundation
Glaucoma Research Foundation Miscellaneous Commercial ServicesCommercial Services Glaucoma Research Foundation provides education services. The non-profit company is based in San Francisco, CA. The company was founded by Adrienne L. Graves. The CEO is Thomas M. Brunner. | Commercial Services |
| Reeve-Irvine Research Center | |
| Allergen Aesthetics |
